Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis.
about
Porphyria cutanea tarda as a complication of therapy for chronic hepatitis CSystemic manifestations of hepatitis C infectionCutaneous manifestations of hepatitis C in the era of new antiviral agentsDermatologic Extrahepatic Manifestations of Hepatitis CGlobal epidemiology and burden of HCV infection and HCV-related disease.Hepatitis C virus-related extra-hepatic disease--aetiopathogenesis and management.Associations among behavior-related susceptibility factors in porphyria cutanea tarda.Ultra high-performance liquid chromatography of porphyrins.Ultra high-performance liquid chromatography of porphyrins in clinical materials: column and mobile phase selection and optimisation.Review.Hepatitis C, porphyria cutanea tarda and liver iron: an update.Clinically important features of porphyrin and heme metabolism and the porphyrias.Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancerExtrahepatic manifestations of hepatitis C infection: navigating CHASM.Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspectiveOral diseases associated with hepatitis C virus infection. Part 2: lichen planus and other diseases.Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patientsCurrent applications of therapeutic phlebotomy.Urban legends series: lichen planus.Role of genetic testing in the management of patients with inherited porphyria and their families.Cutaneous porphyrias part I: epidemiology, pathogenesis, presentation, diagnosis, and histopathology.Non-Hodgkin lymphoma and hepatitis C: where we are and what next?Optimal management of patients with chronic hepatitis C and comorbidities.Hepatitis C virus and autoimmunity.Extrahepatic manifestations of hepatitis C virus (HCV).Extrahepatic manifestations of HCV: the role of direct acting antivirals.Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.Porphyria cutanea tarda: an intriguing genetic disease and marker.Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.Porphyria Cutanea Tarda in a Patient with End-Stage Renal Disease: A Case of Successful Treatment with Deferoxamine and Ferric Carboxymaltose.No association of oral lichen planus and hepatitis C virus infection in central Germany.Hepatitis C- and HIV-induced porphyria cutanea tarda.Systemic abnormalities in liver disease.Bullous lesions in a haemodialysis patient.Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells.Orbital Pseudotumor as an Extrahepatic Complication of Chronic HCV Infection.
P2860
Q24647490-27555FA1-C673-4780-9EBE-9100A5726B94Q26746040-6C8D1A5F-CECE-49F9-9A52-54E52CA05DC5Q26773669-B1F7CFD5-7E59-46B1-8040-346301F2412EQ26781746-4338661B-557A-4255-ABAC-5B5236589997Q30240220-09A8C1E9-9446-49D1-B012-E205AC154C48Q33361560-15A313CD-0C59-4480-AC22-323940CDFF36Q33712331-6BAF85E1-7B7A-4A6C-A2FA-AA55AE844B84Q33952751-32CA2123-F78D-4913-AA48-B5CDD2A414F4Q34059458-6BEEB13B-746F-4D33-BCF4-CEE14DCA532FQ34062040-43B2020E-4012-49CC-A361-093FAEB0ED74Q34268811-858E4EC4-2C8B-4999-B67D-391996DFF37BQ34785744-8BC247AE-FF1B-4ECC-8C66-EC8272F3281DQ35237312-F3B40F9A-455C-465B-B1C8-AA04F00B6063Q36010828-717127EE-1E37-4143-8E0E-CB044BD48423Q36267789-679AE6D6-5B40-4C55-BBD3-E1793BD2935EQ36870118-BB4501C2-E8D5-4B09-A7ED-17CC8B79259CQ37067626-0461DDFE-AFBE-4EEC-86C3-DC39CD48C8B5Q37141723-F829A064-0BCC-4901-83CA-ACFEABB4AB8EQ37602391-0EC7B78F-A9E6-4D4B-A137-B7F76E95198AQ38025689-17A5C743-3CFE-4019-86DF-4515F40F530CQ38100668-616F20F9-2D11-4715-997C-42B8D3C40A2EQ38164825-C78F19BF-5156-413B-89B9-635D69AD3AD2Q38255923-D941AAAE-07F2-4509-8479-5A7807E0CBD9Q38295819-C6688A7A-8D8B-4D06-915D-C190A15F71D3Q38497354-1C6F2928-2E5A-480E-AE66-E960616E2757Q38609093-1350CF93-1D8C-4F5D-97C7-79A551F66A1CQ38684508-0E443DDC-3322-496B-B6DE-20E47F680C63Q38933599-20A48122-C619-45CD-BD0E-E6C7BE367FBDQ39189271-9ACFAE78-DDC5-4B0C-AB53-6886D95570EAQ40051609-A1FF13ED-F17B-4FC1-9AC4-E090C4A8E739Q40328644-686254A8-FA85-4F34-8880-878413B69767Q40978819-3EC74EB7-AC51-4D82-971C-DEF99EA9D0DBQ41890505-0CA2FE2F-385F-4CC8-891B-7B3369C2EB0FQ42623529-E1D4DA14-A52A-4EF9-801D-7CDF467CA188Q48331987-DBE9ACCF-611F-4575-BC52-BE4A15EC8B05Q55231652-DD005651-FC46-4094-9547-A266A29D0A0BQ55553786-D1C42AA8-D2DD-49A1-B7F6-69AF47A7F04A
P2860
Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prevalence of hepatitis C viru ...... atic review and meta-analysis.
@ast
Prevalence of hepatitis C viru ...... atic review and meta-analysis.
@en
type
label
Prevalence of hepatitis C viru ...... atic review and meta-analysis.
@ast
Prevalence of hepatitis C viru ...... atic review and meta-analysis.
@en
prefLabel
Prevalence of hepatitis C viru ...... atic review and meta-analysis.
@ast
Prevalence of hepatitis C viru ...... atic review and meta-analysis.
@en
P2093
P1476
Prevalence of hepatitis C viru ...... matic review and meta-analysis
@en
P2093
José María Pajares
Luisa García-Buey
Ricardo Moreno-Otero
P304
P356
10.1016/S0168-8278(03)00346-5
P577
2003-10-01T00:00:00Z